Minimal Residual Disease Testing in a Clinical Trial for Acute Leukemia
$3,108,907N01FY2018CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
Minimal Residual Disease Testing in a Clinical Trial for Acute Leukemia
View original record on NIH RePORTER →